Invention Grant
- Patent Title: Cyclohexen-1-yl-pyridin-2-yl-1h-pyrazole-4-carboxylic acid derivatives and the use thereof as soluble guanylate cyclase activators
-
Application No.: US15320815Application Date: 2015-07-02
-
Publication No.: US09957254B2Publication Date: 2018-05-01
- Inventor: Christopher M. Adams , David B. Belanger , Doug Bevan , Philippe Bolduc , Takeru Ehara , Luciana Ferrara , Nan Ji , Mitsunori Kato , Erik Meredith , Muneto Mogi , James J. Powers , Ganesh Prasanna
- Applicant: Christopher M. Adams , David B. Belanger , Doug Bevan , Philippe Bolduc , Takeru Ehara , Luciana Ferrara , Nan Ji , Mitsunori Kato , Erik Meredith , Muneto Mogi , James J. Powers , Ganesh Prasanna
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Shawn D. Britt
- International Application: PCT/IB2015/055009 WO 20150702
- International Announcement: WO2016/001878 WO 20160107
- Main IPC: C07D401/14
- IPC: C07D401/14 ; C07D401/04
Abstract:
The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof; a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
Public/Granted literature
Information query
